Literature DB >> 797397

Cyanide and thiocyanate concentrations following sodium nitroprusside infusion in man.

C J Vesey, P V Cole, P J Simpson.   

Abstract

Twenty-six patients, receiving an infusion of sodium nitroprusside (SNP) during surgery, had considerable increases in both red cell and plasma cyanide concentration, but only small changes in plasma thiocyanate concentration. There was a linear relationship between both plasma and RBC cyanide concentrations and the total dose of SNP. The expired cyanide concentration followed the changes in the plasma. We believe that the development of metabolic acidosis, and the recent fatalities involving SNP, are attributable to histotoxic hypoxia as a result of excessive plasma concentrations of cyanide. On the basis of our results, we recommend that the total dose of SNP should not exceed 1.5 mg/kg during short-term infusions and that the plasma cyanide should not exceed 300 nmol%. Plasma thiocyanate concentrations are, in general, an unreliable indication of extent of exposure to cyanide, although they may become important during long-term infusions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 797397     DOI: 10.1093/bja/48.7.651

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  24 in total

Review 1.  Drugs for the perioperative control of hypertension: current issues and future directions.

Authors:  Robert Feneck
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Central nervous system toxicity of sodium nitroprusside in treatment of patients with aortic dissection.

Authors:  Xueyuan Huang; Lingbo Hou; Jiarong Tang; Yanmei Zhang; Fuqiong Chen; Daowen Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

3.  Anaesthetic machine standard.

Authors:  P M McGarry
Journal:  Can Anaesth Soc J       Date:  1978-09

4.  The origin of hydrogen cyanide in breath.

Authors:  P Lundquist; H Rosling; B Sörbo
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

Review 5.  Vasodilators in acute circulatory failure.

Authors:  C Blakeley; J Tinker
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

Review 6.  Clinical pharmacokinetics of nitroprusside, cyanide, thiosulphate and thiocyanate.

Authors:  V Schulz
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

7.  Pharmacology of amygdalin (laetrile) in cancer patients.

Authors:  M M Ames; T P Moyer; J S Kovach; C G Moertel; J Rubin
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

8.  Cyanide toxicity following nitroprusside induced hypotension.

Authors:  D Aitken; D West; F Smith; W Poznanski; J Cowan; J Hurtig; E Peterson; B Benoit
Journal:  Can Anaesth Soc J       Date:  1977-11

9.  Chemical and metabolomic screens identify novel biomarkers and antidotes for cyanide exposure.

Authors:  Anjali K Nath; Lee D Roberts; Yan Liu; Sari B Mahon; Sonia Kim; Justine H Ryu; Andreas Werdich; James L Januzzi; Gerry R Boss; Gary A Rockwood; Calum A MacRae; Matthew Brenner; Robert E Gerszten; Randall T Peterson
Journal:  FASEB J       Date:  2013-01-23       Impact factor: 5.191

Review 10.  Current management of hypertensive emergencies.

Authors:  J Y Garcia; D G Vidt
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.